+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gene Fusion Testing Market - Global Forecast 2026-2032- Product Image
Gene Fusion Testing Market - Global Forecast 2026-2032- Product Image
New

Gene Fusion Testing Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 184 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5924686
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The gene fusion testing market has emerged as a pivotal segment within precision diagnostics, evolving rapidly to keep pace with new technology, clinical advancements, and shifting demands across global healthcare systems. Senior decision-makers in diagnostics, biopharma, and healthcare face a landscape requiring strategic alignment of innovation, operational execution, and market strategy.

Market Snapshot: Gene Fusion Testing Market Size and Growth

The gene fusion testing market expanded from USD 324.53 million in 2025 to USD 347.39 million in 2026. Forecasts anticipate the market will grow at a CAGR of 6.28%, achieving USD 497.39 million by 2032. This growth reflects heightened investment in molecular diagnostics, accelerating clinical demand for targeted therapeutic guidance, and the extension of testing into new, relevant clinical indications. Market momentum is driven by the push for enhanced patient stratification and integration into clinical decision-making, as organizations seek scalable solutions for evolving diagnostic needs.

Scope & Segmentation of the Gene Fusion Testing Market

This market demonstrates dynamic segmentation across technologies, applications, user groups, and regions, revealing evolving priorities and differentiated adoption criteria among stakeholders.

  • Technology Types: Next-generation sequencing (NGS), fluorescence in situ hybridization (FISH), immunohistochemistry (IHC), and reverse transcription polymerase chain reaction (RT-PCR) serve distinct requirements for diagnostic accuracy, workflow integration, and confirmation of gene fusion events. These tools can work in concert to enhance diagnostic confidence for clinicians and laboratorians.
  • Sample Types: Blood-based assays, including plasma and serum, bring minimally invasive monitoring options, while tissue-based analyses from formalin-fixed paraffin embedded specimens or fresh frozen tissue allow deeper characterization of fusion events and are favored in certain settings for diagnostic certainty.
  • Clinical Applications: Oncology leads adoption, with targeted gene panels benefiting breast, lung, colorectal, and prostate cancers, while hematology applications support management of leukemia and lymphoma. The segment also engages rare disease diagnostics, including developmental and neuromuscular disorders, broadening its clinical utility.
  • End Users: Hospital-based and reference laboratories, pharmaceutical and biotechnology companies, academic centers, and private research labs each bring unique service models, with differing requirements for workflow customization, evidence standards, and data integration.
  • Geographical Regions: The Americas, Europe, Middle East & Africa, and Asia-Pacific show distinct regulatory pathways, reimbursement policies, and diagnostic infrastructure, influencing regional adoption rates and deployment strategies.

Key Takeaways: Strategic Decision Points in the Gene Fusion Testing Market

  • Diagnostic workflows increasingly integrate cross-functional collaboration, moving gene fusion testing from specialized research to standard clinical practice.
  • Ongoing assay development and the rise of comprehensive genomic panels enable personalized care and ongoing monitoring, meeting evolving therapy guidance requirements.
  • Collaboration between diagnostic vendors, pharmaceutical developers, and care providers propels integration into clinical trials and companion diagnostics, supporting pharmaceutical R&D goals.
  • Diverse regional regulations and reimbursement models require market adaptation with tailored market access strategies and variable pricing to engage different health systems efficiently.
  • Supply chain resilience, through supplier diversification and regional manufacturing, minimizes logistic disruption and tariff impact for operational stability.
  • Clear evidence of clinical utility, leveraging robust data generation and clinician education, is critical to drive adoption, especially in broad laboratory or hospital networks.

Tariff Impact on Procurement and Supply Chain Strategies

Evolving US tariff regulations have compelled diagnostic organizations to reassess procurement, supply chain, and manufacturing approaches. Businesses now emphasize regional manufacturing, diversify suppliers, and create strategic inventory buffers to mitigate increased costs and delivery uncertainty. Procurement leaders employ detailed cost-of-ownership analyses that account for tariffs, customs, and logistics to enhance resilience and assure continuity of laboratory operations.

Methodology & Data Sources

This report utilizes expert interviews with laboratory directors, molecular pathologists, and clinical trial leaders, combined with systematic reviews of peer-reviewed literature and regulatory documentation. Performance metrics and procedural standards were applied to ensure actionable, high-confidence findings.

Why This Report Matters

  • Enables informed strategic planning for technology investment, clinical validation, and regional market access for stakeholders in diagnostics, pharmaceuticals, and healthcare services.
  • Identifies operational priorities—such as workflow integration, robust evidence generation, and resilient supply chains—that directly influence market adoption and risk reduction.
  • Guides deployment by providing regulatory insights, highlighting clinician education needs, and clarifying regional infrastructure requirements for effective rollout.

Conclusion

Gene fusion testing stands as a pivotal element in advancing precision medicine. By integrating technology innovation, operational best practices, and regional market strategies, leadership teams can position their organizations for sustainable growth and improved patient outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Gene Fusion Testing Market, by Technology
8.1. Fluorescence In Situ Hybridization
8.2. Immunohistochemistry
8.3. Next Generation Sequencing
8.3.1. Targeted Next Generation Sequencing
8.3.2. Transcriptome Sequencing
8.3.3. Whole Genome Sequencing
8.4. Reverse Transcription Polymerase Chain Reaction
9. Gene Fusion Testing Market, by Sample Type
9.1. Blood
9.1.1. Plasma
9.1.2. Serum
9.2. Tissue
9.2.1. Formalin Fixed Paraffin Embedded
9.2.2. Fresh Frozen Tissue
10. Gene Fusion Testing Market, by Application
10.1. Hematology
10.1.1. Leukemia
10.1.2. Lymphoma
10.2. Oncology
10.2.1. Breast Cancer
10.2.2. Colorectal Cancer
10.2.3. Lung Cancer
10.2.4. Prostate Cancer
10.3. Rare Diseases
10.3.1. Developmental Disorders
10.3.2. Neuromuscular Disorders
11. Gene Fusion Testing Market, by End User
11.1. Diagnostic Laboratories
11.1.1. Hospital Based Laboratories
11.1.2. Independent Laboratories
11.2. Hospitals
11.2.1. Inpatient Facilities
11.2.2. Outpatient Clinics
11.3. Pharmaceutical Companies
11.3.1. Biotechnology Companies
11.3.2. Pharma Giants
11.4. Research Institutions
11.4.1. Academic Centers
11.4.2. Private Research Laboratories
12. Gene Fusion Testing Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Gene Fusion Testing Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Gene Fusion Testing Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Gene Fusion Testing Market
16. China Gene Fusion Testing Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Amoy Diagnostics Co., Ltd.
17.6. Arima Genomics, Inc.
17.7. Biocare Medical, LLC
17.8. Biocartis NV
17.9. Caris Life Sciences
17.10. Danaher Corporation
17.11. Empire Genomics, Inc.
17.12. F. Hoffmann-La Roche Ltd.
17.13. Guardant Health, Inc.
17.14. Illumina, Inc.
17.15. Integrated DNA Technologies, Inc.
17.16. Myriad Genetics, Inc.
17.17. Natera, Inc.
17.18. NeoGenomics, Inc.
17.19. OncoDNA SA
17.20. Paragon Genomics, Inc.
17.21. QIAGEN N.V.
17.22. Quest Diagnostics Incorporated.
17.23. SOPHiA GENETICS SA
17.24. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL GENE FUSION TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL GENE FUSION TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL GENE FUSION TESTING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL GENE FUSION TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL GENE FUSION TESTING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL GENE FUSION TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL GENE FUSION TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL GENE FUSION TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL GENE FUSION TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES GENE FUSION TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA GENE FUSION TESTING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL GENE FUSION TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL GENE FUSION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL GENE FUSION TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL GENE FUSION TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL GENE FUSION TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL GENE FUSION TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL GENE FUSION TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL GENE FUSION TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL GENE FUSION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL GENE FUSION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL GENE FUSION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL GENE FUSION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL GENE FUSION TESTING MARKET SIZE, BY TARGETED NEXT GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL GENE FUSION TESTING MARKET SIZE, BY TARGETED NEXT GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL GENE FUSION TESTING MARKET SIZE, BY TARGETED NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL GENE FUSION TESTING MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL GENE FUSION TESTING MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL GENE FUSION TESTING MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL GENE FUSION TESTING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL GENE FUSION TESTING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL GENE FUSION TESTING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL GENE FUSION TESTING MARKET SIZE, BY REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL GENE FUSION TESTING MARKET SIZE, BY REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL GENE FUSION TESTING MARKET SIZE, BY REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL GENE FUSION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL GENE FUSION TESTING MARKET SIZE, BY BLOOD, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL GENE FUSION TESTING MARKET SIZE, BY BLOOD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL GENE FUSION TESTING MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL GENE FUSION TESTING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL GENE FUSION TESTING MARKET SIZE, BY PLASMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL GENE FUSION TESTING MARKET SIZE, BY PLASMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL GENE FUSION TESTING MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL GENE FUSION TESTING MARKET SIZE, BY SERUM, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL GENE FUSION TESTING MARKET SIZE, BY SERUM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL GENE FUSION TESTING MARKET SIZE, BY SERUM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL GENE FUSION TESTING MARKET SIZE, BY TISSUE, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL GENE FUSION TESTING MARKET SIZE, BY TISSUE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL GENE FUSION TESTING MARKET SIZE, BY TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL GENE FUSION TESTING MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL GENE FUSION TESTING MARKET SIZE, BY FORMALIN FIXED PARAFFIN EMBEDDED, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL GENE FUSION TESTING MARKET SIZE, BY FORMALIN FIXED PARAFFIN EMBEDDED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL GENE FUSION TESTING MARKET SIZE, BY FORMALIN FIXED PARAFFIN EMBEDDED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL GENE FUSION TESTING MARKET SIZE, BY FRESH FROZEN TISSUE, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL GENE FUSION TESTING MARKET SIZE, BY FRESH FROZEN TISSUE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL GENE FUSION TESTING MARKET SIZE, BY FRESH FROZEN TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL GENE FUSION TESTING MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL GENE FUSION TESTING MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL GENE FUSION TESTING MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL GENE FUSION TESTING MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL GENE FUSION TESTING MARKET SIZE, BY LEUKEMIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL GENE FUSION TESTING MARKET SIZE, BY LEUKEMIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL GENE FUSION TESTING MARKET SIZE, BY LEUKEMIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL GENE FUSION TESTING MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL GENE FUSION TESTING MARKET SIZE, BY LYMPHOMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL GENE FUSION TESTING MARKET SIZE, BY LYMPHOMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL GENE FUSION TESTING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL GENE FUSION TESTING MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL GENE FUSION TESTING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL GENE FUSION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL GENE FUSION TESTING MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL GENE FUSION TESTING MARKET SIZE, BY BREAST CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL GENE FUSION TESTING MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL GENE FUSION TESTING MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL GENE FUSION TESTING MARKET SIZE, BY COLORECTAL CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL GENE FUSION TESTING MARKET SIZE, BY COLORECTAL CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL GENE FUSION TESTING MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL GENE FUSION TESTING MARKET SIZE, BY LUNG CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL GENE FUSION TESTING MARKET SIZE, BY LUNG CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL GENE FUSION TESTING MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL GENE FUSION TESTING MARKET SIZE, BY PROSTATE CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL GENE FUSION TESTING MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL GENE FUSION TESTING MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL GENE FUSION TESTING MARKET SIZE, BY RARE DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL GENE FUSION TESTING MARKET SIZE, BY RARE DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL GENE FUSION TESTING MARKET SIZE, BY RARE DISEASES, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL GENE FUSION TESTING MARKET SIZE, BY DEVELOPMENTAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL GENE FUSION TESTING MARKET SIZE, BY DEVELOPMENTAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL GENE FUSION TESTING MARKET SIZE, BY DEVELOPMENTAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL GENE FUSION TESTING MARKET SIZE, BY NEUROMUSCULAR DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL GENE FUSION TESTING MARKET SIZE, BY NEUROMUSCULAR DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL GENE FUSION TESTING MARKET SIZE, BY NEUROMUSCULAR DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL GENE FUSION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL GENE FUSION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL GENE FUSION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL GENE FUSION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL GENE FUSION TESTING MARKET SIZE, BY HOSPITAL BASED LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL GENE FUSION TESTING MARKET SIZE, BY HOSPITAL BASED LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL GENE FUSION TESTING MARKET SIZE, BY HOSPITAL BASED LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL GENE FUSION TESTING MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL GENE FUSION TESTING MARKET SIZE, BY INDEPENDENT LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL GENE FUSION TESTING MARKET SIZE, BY INDEPENDENT LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL GENE FUSION TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL GENE FUSION TESTING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL GENE FUSION TESTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL GENE FUSION TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL GENE FUSION TESTING MARKET SIZE, BY INPATIENT FACILITIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL GENE FUSION TESTING MARKET SIZE, BY INPATIENT FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL GENE FUSION TESTING MARKET SIZE, BY INPATIENT FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL GENE FUSION TESTING MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL GENE FUSION TESTING MARKET SIZE, BY OUTPATIENT CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL GENE FUSION TESTING MARKET SIZE, BY OUTPATIENT CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL GENE FUSION TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL GENE FUSION TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL GENE FUSION TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL GENE FUSION TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL GENE FUSION TESTING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL GENE FUSION TESTING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL GENE FUSION TESTING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL GENE FUSION TESTING MARKET SIZE, BY PHARMA GIANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL GENE FUSION TESTING MARKET SIZE, BY PHARMA GIANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL GENE FUSION TESTING MARKET SIZE, BY PHARMA GIANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL GENE FUSION TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL GENE FUSION TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL GENE FUSION TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL GENE FUSION TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL GENE FUSION TESTING MARKET SIZE, BY ACADEMIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL GENE FUSION TESTING MARKET SIZE, BY ACADEMIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL GENE FUSION TESTING MARKET SIZE, BY ACADEMIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL GENE FUSION TESTING MARKET SIZE, BY PRIVATE RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL GENE FUSION TESTING MARKET SIZE, BY PRIVATE RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL GENE FUSION TESTING MARKET SIZE, BY PRIVATE RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL GENE FUSION TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. AMERICAS GENE FUSION TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 126. AMERICAS GENE FUSION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 127. AMERICAS GENE FUSION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 128. AMERICAS GENE FUSION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 129. AMERICAS GENE FUSION TESTING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 130. AMERICAS GENE FUSION TESTING MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
TABLE 131. AMERICAS GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 132. AMERICAS GENE FUSION TESTING MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 133. AMERICAS GENE FUSION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 134. AMERICAS GENE FUSION TESTING MARKET SIZE, BY RARE DISEASES, 2018-2032 (USD MILLION)
TABLE 135. AMERICAS GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 136. AMERICAS GENE FUSION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 137. AMERICAS GENE FUSION TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 138. AMERICAS GENE FUSION TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 139. AMERICAS GENE FUSION TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 140. NORTH AMERICA GENE FUSION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. NORTH AMERICA GENE FUSION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 142. NORTH AMERICA GENE FUSION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 143. NORTH AMERICA GENE FUSION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 144. NORTH AMERICA GENE FUSION TESTING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 145. NORTH AMERICA GENE FUSION TESTING MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
TABLE 146. NORTH AMERICA GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 147. NORTH AMERICA GENE FUSION TESTING MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 148. NORTH AMERICA GENE FUSION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 149. NORTH AMERICA GENE FUSION TESTING MARKET SIZE, BY RARE DISEASES, 2018-2032 (USD MILLION)
TABLE 150. NORTH AMERICA GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 151. NORTH AMERICA GENE FUSION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 152. NORTH AMERICA GENE FUSION TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 153. NORTH AMERICA GENE FUSION TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 154. NORTH AMERICA GENE FUSION TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 155. LATIN AMERICA GENE FUSION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. LATIN AMERICA GENE FUSION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 157. LATIN AMERICA GENE FUSION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 158. LATIN AMERICA GENE FUSION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 159. LATIN AMERICA GENE FUSION TESTING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 160. LATIN AMERICA GENE FUSION TESTING MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
TABLE 161. LATIN AMERICA GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 162. LATIN AMERICA GENE FUSION TESTING MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 163. LATIN AMERICA GENE FUSION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 164. LATIN AMERICA GENE FUSION TESTING MARKET SIZE, BY RARE DISEASES, 2018-2032 (USD MILLION)
TABLE 165. LATIN AMERICA GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 166. LATIN AMERICA GENE FUSION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 167. LATIN AMERICA GENE FUSION TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 168. LATIN AMERICA GENE FUSION TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 169. LATIN AMERICA GENE FUSION TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY RARE DISEASES, 2018-2032 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 185. EUROPE GENE FUSION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 186. EUROPE GENE FUSION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 187. EUROPE GENE FUSION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 188. EUROPE GENE FUSION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 189. EUROPE GENE FUSION TESTING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 190. EUROPE GENE FUSION TESTING MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
TABLE 191. EUROPE GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 192. EUROPE GENE FUSION TESTING MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 193. EUROPE GENE FUSION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 194. EUROPE GENE FUSION TESTING MARKET SIZE, BY RARE DISEASES, 2018-2032 (USD MILLION)
TABLE 195. EUROPE GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 196. EUROPE GENE FUSION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 197. EUROPE GENE FUSION TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 198. EUROPE GENE FUSION TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 199. EUROPE GENE FUSION TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 200. MIDDLE EAST GENE FUSION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 201. MIDDLE EAST GENE FUSION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 202. MIDDLE EAST GENE FUSION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 203. MIDDLE EAST GENE FUSION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 204. MIDDLE EAST GENE FUSION TESTING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 205. MIDDLE EAST GENE FUSION TESTING MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
TABLE 206. MIDDLE EAST GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 207. MIDDLE EAST GENE FUSION TESTING MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 208. MIDDLE EAST GENE FUSION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 209. MIDDLE EAST GENE FUSION TESTING MARKET SIZE, BY RARE DISEASES, 2018-2032 (USD MILLION)
TABLE 210. MIDDLE EAST GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 211. MIDDLE EAST GENE FUSION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 212. MIDDLE EAST GENE FUSION TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 213. MIDDLE EAST GENE FUSION TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 214. MIDDLE EAST GENE FUSION TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 215. AFRICA GENE FUSION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 216. AFRICA GENE FUSION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 217. AFRICA GENE FUSION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 218. AFRICA GENE FUSION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 219. AFRICA GENE FUSION TESTING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 220. AFRICA GENE FUSION TESTING MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
TABLE 221. AFRICA GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 222. AFRICA GENE FUSION TESTING MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 223. AFRICA GENE FUSION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 224. AFRICA GENE FUSION TESTING MARKET SIZE, BY RARE DISEASES, 2018-2032 (USD MILLION)
TABLE 225. AFRICA GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 226. AFRICA GENE FUSION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 227. AFRICA GENE FUSION TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 228. AFRICA GENE FUSION TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 229. AFRICA GENE FUSION TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 230. ASIA-PACIFIC GENE FUSION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 231. ASIA-PACIFIC GENE FUSION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 232. ASIA-PACIFIC GENE FUSION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 233. ASIA-PACIFIC GENE FUSION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 234. ASIA-PACIFIC GENE FUSION TESTING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 235. ASIA-PACIFIC GENE FUSION TESTING MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
TABLE 236. ASIA-PACIFIC GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 237. ASIA-PACIFIC GENE FUSION TESTING MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 238. ASIA-PACIFIC GENE FUSION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 239. ASIA-PACIFIC GENE FUSION TESTING MARKET SIZE, BY RARE DISEASES, 2018-2032 (USD MILLION)
TABLE 240. ASIA-PACIFIC GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 241. ASIA-PACIFIC GENE FUSION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 242. ASIA-PACIFIC GENE FUSION TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 243. ASIA-PACIFIC GENE FUSION TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 244. ASIA-PACIFIC GENE FUSION TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 245. GLOBAL GENE FUSION TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 246. ASEAN GENE FUSION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 247. ASEAN GENE FUSION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 248. ASEAN GENE FUSION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 249. ASEAN GENE FUSION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 250. ASEAN GENE FUSION TESTING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 251. ASEAN GENE FUSION TESTING MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
TABLE 252. ASEAN GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 253. ASEAN GENE FUSION TESTING MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 254. ASEAN GENE FUSION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 255. ASEAN GENE FUSION TESTING MARKET SIZE, BY RARE DISEASES, 2018-2032 (USD MILLION)
TABLE 256. ASEAN GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 257. ASEAN GENE FUSION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 258. ASEAN GENE FUSION TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 259. ASEAN GENE FUSION TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 260. ASEAN GENE FUSION TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 261. GCC GENE FUSION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 262. GCC GENE FUSION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 263. GCC GENE FUSION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 264. GCC GENE FUSION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 265. GCC GENE FUSION TESTING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 266. GCC GENE FUSION TESTING MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
TABLE 267. GCC GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 268. GCC GENE FUSION TESTING MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 269. GCC GENE FUSION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 270. GCC GENE FUSION TESTING MARKET SIZE, BY RARE DISEASES, 2018-2032 (USD MILLION)
TABLE 271. GCC GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 272. GCC GENE FUSION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 273. GCC GENE FUSION TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 274. GCC GENE FUSION TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 275. GCC GENE FUSION TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 276. EUROPEAN UNION GENE FUSION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 277. EUROPEAN UNION GENE FUSION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 278. EUROPEAN UNION GENE FUSION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 279. EUROPEAN UNION GENE FUSION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 280. EUROPEAN UNION GENE FUSION TESTING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 281. EUROPEAN UNION GENE FUSION TESTING MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
TABLE 282. EUROPEAN UNION GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 283. EUROPEAN UNION GENE FUSION TESTING MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 284. EUROPEAN UNION GENE FUSION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 285. EUROPEAN UNION GENE FUSION TESTING MARKET SIZE, BY RARE DISEASES, 2018-2032 (USD MILLION)
TABLE 286. EUROPEAN UNION GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 287. EUROPEAN UNION GENE FUSION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 288. EUROPEAN UNION GENE FUSION TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 289. EUROPEAN UNION GENE FUSION TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 290. EUROPEAN UNION GENE FUSION TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 291. BRICS GENE FUSION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 292. BRICS GENE FUSION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 293. BRICS GENE FUSION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 294. BRICS GENE FUSION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 295. BRICS GENE FUSION TESTING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 296. BRICS GENE FUSION TESTING MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
TABLE 297. BRICS GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 298. BRICS GENE FUSION TESTING MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 299. BRICS GENE FUSION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 300. BRICS GENE FUSION TESTING MARKET SIZE, BY RARE DISEASES, 2018-2032 (USD MILLION)
TABLE 301. BRICS GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 302. BRICS GENE FUSION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 303. BRICS GENE FUSION TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 304. BRICS GENE FUSION TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 305. BRICS GENE FUSION TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 306. G7 GENE FUSION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 307. G7 GENE FUSION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 308. G7 GENE FUSION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 309. G7 GENE FUSION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 310. G7 GENE FUSION TESTING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 311. G7 GENE FUSION TESTING MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
TABLE 312. G7 GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 313. G7 GENE FUSION TESTING MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 314. G7 GENE FUSION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 315. G7 GENE FUSION TESTING MARKET SIZE, BY RARE DISEASES, 2018-2032 (USD MILLION)
TABLE 316. G7 GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 317. G7 GENE FUSION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 318. G7 GENE FUSION TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 319. G7 GENE FUSION TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 320. G7 GENE FUSION TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 321. NATO GENE FUSION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 322. NATO GENE FUSION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 323. NATO GENE FUSION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 324. NATO GENE FUSION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 325. NATO GENE FUSION TESTING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 326. NATO GENE FUSION TESTING MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
TABLE 327. NATO GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 328. NATO GE

Companies Mentioned

The key companies profiled in this Gene Fusion Testing market report include:
  • Amoy Diagnostics Co., Ltd.
  • Arima Genomics, Inc.
  • Biocare Medical, LLC
  • Biocartis NV
  • Caris Life Sciences
  • Danaher Corporation
  • Empire Genomics, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Guardant Health, Inc.
  • Illumina, Inc.
  • Integrated DNA Technologies, Inc.
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • NeoGenomics, Inc.
  • OncoDNA SA
  • Paragon Genomics, Inc.
  • QIAGEN N.V.
  • Quest Diagnostics Incorporated.
  • SOPHiA GENETICS SA
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages184
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 347.39 Million
Forecasted Market Value ( USD ) by 2032 $ 497.39 Million
Compound Annual Growth Rate6.2%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Gene Fusion Testing Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F - Product Image

Gene Fusion Testing Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Gene Fusion Testing Market - A Global and Regional Analysis: Focus on Category, Technology, Indication, End User, and Region - Analysis and Forecast, 2025-2035 - Product Image

Gene Fusion Testing Market - A Global and Regional Analysis: Focus on Category, Technology, Indication, End User, and Region - Analysis and Forecast, 2025-2035

  • Report
  • 130 Pages
  • Global
From
Neuregulin Gene Kit Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Neuregulin Gene Kit Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Lung Cancer Genomic Testing Market - Global Forecast 2026-2032 - Product Image

Lung Cancer Genomic Testing Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Global Gene Fusion Testing Market - Product Image

Global Gene Fusion Testing Market

  • Report
  • 79 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.